Gossamer Bio Inc expected to post a loss of 62 cents a share - Earnings Preview

Gossamer Bio

28/02/2023 02:10

* Gossamer Bio Inc  GOSS.OQ   GOSS.O  is expected to show no
change in quarterly revenue when it reports  results on March 1
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Gossamer Bio Inc is
for a
loss of 62 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $7​, above​ its last closing price of $1.76. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.66       -0.64      -0.65     Missed  -2.3
 Jun. 30 2022  -0.68       -0.70      -0.74     Missed  -5.8
 Mar. 31 2022  -0.77       -0.77      -0.76     Beat    0.9​
 Dec. 31 2021  -0.74       -0.74      -0.74     Met     0.4
 ​​Sep.        -0.78       -0.78      -0.80     Missed  -1.9
 30 2021                                                
 Jun. 30 2021  -0.76       -0.76      -0.80     Missed  -5.6​
 Mar. 31 2021  -0.76       -0.75      -0.78     Missed  -3.7
 Dec. 31 2020  -0.82       -0.79      -0.88     Missed  -11.4
 This summary was machine generated February 28 at 02:10 GMT. 
All figures in US dollars  unless otherwise stated